首页> 外文OA文献 >Report on mutation in exon 15 of the APC gene in a case of brain metastasis
【2h】

Report on mutation in exon 15 of the APC gene in a case of brain metastasis

机译:关于脑转移病例中apC基因外显子15突变的报道

摘要

The study analyzes exon 15 of the adenomatous polyposis coli gene (APC) in a 49-year-old male patient with brain metastasis. The primary site was lung carcinoma. PCR method and direct DNA sequencing of the metastasis and autologous lymphocyte samples identified the presence of a somatic mutation. The substitution was at position 5883 G-A in the metastasis tissue. The mutation was confirmed by RFLP analysis using Msp I endonuclease, since the mutation strikes the Msp I restriction site. Immunohistochemical analysis revealed the lack of protein expression of this tumor suppressor gene. The main molecular activator of the wnt pathway, beta-catenin, was expressed, and located in the nucleus. The mutation is a silent mutation that might have consequences in the creation of a new splice site. Different single-base substitutions in APC exons need not only be evaluated by the predicted change in amino acid sequence, but rather at the nucleotide level itself. In our opinion, such silent mutations should also be incorporated in mutation detection rate and validation.
机译:这项研究分析了一名49岁男性脑转移患者的腺瘤性息肉病大肠杆菌基因(APC)的第15外显子。原发部位是肺癌。转移和自体淋巴细胞样品的PCR方法和直接DNA测序确定了体细胞突变的存在。取代在转移组织中的5883 G-A位置。该突变通过使用Msp I核酸内切酶的RFLP分析得以证实,因为该突变到达Msp I限制性酶切位点。免疫组织化学分析显示该肿瘤抑制基因缺乏蛋白质表达。 wnt途径的主要分子激活剂,β-连环蛋白,被表达并位于细胞核中。该突变是一个沉默突变,可能对创建新的剪接位点产生影响。 APC外显子中不同的单碱基取代不仅需要通过预测的氨基酸序列变化来评估,而且需要在核苷酸水平上进行评估。我们认为,此类沉默突变也应纳入突变检测率和验证中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号